Dr. Janice Mullins, D.O.
What this data tells you about Dr. Mullins
Dr. Janice Mullins is an internal medicine specialist in San Antonio, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mullins performed 40,843 Medicare services across 3,424 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mullins received a total of $1,291 from 21 pharmaceutical and/or device companies across 44 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mullins is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 11,730 | $0 | $5 |
| Iron sucrose injection (Venofer) | 8,700 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 6,150 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 3,428 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,410 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 960 | $17 | $67 |
| Anti-nausea injection (Aloxi/palonosetron) | 760 | $1 | $114 |
| Comprehensive metabolic blood panel | 754 | $10 | $64 |
| Complete blood count (CBC) with differential | 744 | $8 | $36 |
| Blood draw (venipuncture) | 666 | $8 | $20 |
| Office visit, established patient (20-29 min) | 516 | $60 | $250 |
| Injection, granisetron hydrochloride, 100 mcg | 450 | $0 | $24 |
| Ferritin level test (iron stores) | 304 | $13 | $60 |
| Iron level test | 304 | $6 | $27 |
| Iron binding capacity test | 304 | $9 | $35 |
| Immunoglobulin level test | 303 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 241 | $22 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 230 | $97 | $707 |
| Vitamin B-12 level test | 205 | $15 | $76 |
| Measurement of immunoglobulin light chains | 204 | $17 | $60 |
| Office visit, established patient (30-39 min) | 201 | $94 | $368 |
| Injection, carboplatin, 50 mg | 198 | $2 | $300 |
| Folic acid level test | 197 | $14 | $73 |
| Injection, zoledronic acid, 1 mg | 141 | $7 | $431 |
| Drug injection, under skin or into muscle | 101 | $10 | $96 |
| Office visit, established patient, complex (40-54 min) | 101 | $120 | $496 |
| Lactate dehydrogenase (enzyme) level | 100 | $6 | $31 |
| Administration of additional new drug or substance into vein, 1 hour or less | 94 | $48 | $344 |
| Carcinoembryonic antigen (cea) protein level | 88 | $19 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 86 | $48 | $313 |
| Hospital follow-up visit, high complexity | 86 | $90 | $357 |
| Prothrombin time test (blood clotting) | 77 | $4 | $30 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 67 | $20 | $128 |
| Infusion, normal saline solution , 1000 cc | 67 | $2 | $19 |
| Injection, diphenhydramine hcl, up to 50 mg | 62 | $1 | $7 |
| Hospital follow-up visit, moderate complexity | 56 | $59 | $247 |
| Unclassified drugs | 56 | $1 | $8 |
| Infusion into a vein for hydration, each additional hour | 44 | $10 | $75 |
| Administration of chemotherapy into vein, each additional hour | 43 | $21 | $161 |
| New patient office visit (45-59 min) | 43 | $119 | $565 |
| Injection of additional new drug or substance into vein | 38 | $11 | $108 |
| Ct scan of chest with contrast | 37 | $49 | $821 |
| Microscopic examination for white blood cells with manual cell count | 36 | $4 | $22 |
| Complete blood count (CBC), automated | 36 | $6 | $34 |
| Reticulated (young) platelet measurement | 35 | $35 | $143 |
| Thyroid stimulating hormone (TSH) test | 33 | $16 | $80 |
| Red blood count automated, with additional calculations | 33 | $5 | $26 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 32 | $53 | $211 |
| Beta-2 microglobulin (protein) level | 31 | $16 | $96 |
| CT scan of abdomen and pelvis with contrast | 29 | $165 | $1,067 |
| Irrigation of implanted venous access drug delivery device | 28 | $17 | $114 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 27 | $272 | $2,762 |
| Initial hospital admission, high complexity | 25 | $112 | $694 |
| Sed rate test (inflammation marker) | 24 | $3 | $36 |
| Infusion into a vein for hydration, 31-60 minutes | 24 | $23 | $256 |
| New patient office visit, complex (60-74 min) | 22 | $143 | $709 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 21 | $178 | $700 |
| Initial hospital admission, moderate complexity | 16 | $100 | $470 |
| Haptoglobin (serum protein) level | 15 | $12 | $66 |
| C-reactive protein test (inflammation marker) | 15 | $5 | $33 |
| Drawing of blood for a medical problem | 15 | $70 | $264 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mullins is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mullins experienced with iron infusion (feraheme)?
Does Dr. Mullins receive payments from pharmaceutical companies?
How do Dr. Mullins's costs compare to other internal medicine physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology